Synendos Therapeutics granted EMA clinical trial authorisation

BASEL, Switzerland, 18 January 2024 - Synendos Therapeutics AG, a world leader in innovative Endocannabinoid System (ECS) treatments, today announces that it has received approval…
andy18.01.2024